Related Experiment Video
Updated: Jan 5, 2026

11:31
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
18.4K
Successful granulocyte apheresis using medium molecular weight hydroxyethyl starch
Mai Nanya1, Kimiko Yurugi1, Itaru Kato2
1Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
International Journal of Hematology
|October 12, 2019
Summary
Medium molecular weight hydroxyethyl starch (HES) with the Spectra Optia system effectively collects granulocytes for transfusion. This method provides a safe and viable alternative when high molecular weight HES is unavailable.
Area of Science:
- Hematology
- Transfusion Medicine
- Apheresis Technology
Background:
- Granulocyte transfusion (GTX) is crucial for managing severe infections in neutropenic patients.
- High molecular weight hydroxyethyl starch (HES) aids red blood cell sedimentation in apheresis but has limited availability.
- Alternative HES formulations are needed for efficient granulocyte collection.
Purpose of the Study:
- To evaluate the efficacy of medium molecular weight HES (130 kDa) combined with the Spectra Optia apheresis system for granulocyte collection.
- To assess the feasibility of this method in settings where high molecular weight HES is not accessible.
Main Methods:
- Granulocyte collection was performed using the Spectra Optia apheresis system with medium molecular weight HES.
- Apheresis procedures were conducted on seven donors over two consecutive days.
- Neutrophil yield and post-transfusion counts were analyzed.
Main Results:
- The mean total neutrophil yield was 5.27 × 10^10 on day 1 and 2.91 × 10^10 on day 2.
- Infusion of Day 1 apheresis products significantly increased neutrophil counts in recipients.
- Day 2 apheresis products were sufficient for maintaining neutrophil counts.
Conclusions:
- Medium molecular weight HES in conjunction with the Spectra Optia system enables efficient granulocyte harvesting.
- This strategy offers a safe and effective clinical practice for GTX, particularly where high molecular weight HES is unavailable.

